Business
50 years of US unemployment: Biden has inherited the reins of a fragile economy — we get some historical context

50 years of US unemployment: Biden has inherited the reins of a fragile economy — we get some historical context

Joe Biden is officially in the Oval Office. In his first few days as President, Biden focused his attention on repealing a number of Executive Orders put in place by his predecessor, before turning his efforts towards the country's coronavirus response.

A fragile, but recovering economy

Once COVID-19 is under control Biden's primary focus will likely turn to the US economy, which is in a fragile, but not critical, state.

The Bureau of Labor Statistics pegs the latest US unemployment rate at 6.7%. Incredibly, that's actually down from the 14.8% that it peaked at back in April of last year — a testament to how far the economy has come in just 8 months.

Relative to history, an economy with an unemployment rate of 6.7% is actually fairly **un**remarkable — the average for the last 50 years is 6.2% and many past presidents have taken the reins of an economy in much worse shape. Reagan entered the office with unemployment at 7.4%, Clinton at 7.1% and Obama took over as unemployment was climbing towards 10% during the depths of the global financial crisis at the start of '09.

Okay — so not too bad then?

The issue is whether the sharp rebound continues. If you look at the data on total number of people employed, the economic recovery looks like it has flatlined. Similarly, more recently available data (such as unemployment claims) remain painfully high.

The glass-half-empty view is that once the huge stimulus packages injected into the economy subside, with some provisions expiring in mid-March, the economy could collapse again.

The glass-half-full argument is even simpler: people are going to go mad for all of the things they have missed (holidays, dining out etc.) — and many have been saving over the last 10 months.

More Business

See all Business
The Sphere In Las Vegas

Washington D.C. looks set to get America’s second Sphere

Revenue for the Las Vegas version of the big orb has soared, but the sphere is still a money pit.

business

Ford reportedly in talks to buy hybrid vehicle batteries from Chinese auto giant BYD

Detroit’s Ford and China’s BYD are said to be in ongoing talks to partner on an agreement that would see Ford buy hybrid vehicle batteries from BYD, according to reporting from The Wall Street Journal.

The report comes just days after President Trump toured a Ford factory in Michigan and implied openness to Chinese automakers coming to the US.

“If they want to come in and build a plant... that’s great, I love that,” Trump said on January 13. “Let China come in, let Japan come in.”

Last week, China’s Geely Automobile Holdings said it expects to make an announcement about expanding into the US within the next three years. Chinese carmakers currently face huge tariffs and software restrictions, effectively barring their vehicles from the US.

Ford has doubled down on hybrid vehicles amid high EV costs and the end of federal EV tax credits. The automaker is currently building a battery plant in Michigan where it plans to use tech from Chinese battery maker CATL.

“If they want to come in and build a plant... that’s great, I love that,” Trump said on January 13. “Let China come in, let Japan come in.”

Last week, China’s Geely Automobile Holdings said it expects to make an announcement about expanding into the US within the next three years. Chinese carmakers currently face huge tariffs and software restrictions, effectively barring their vehicles from the US.

Ford has doubled down on hybrid vehicles amid high EV costs and the end of federal EV tax credits. The automaker is currently building a battery plant in Michigan where it plans to use tech from Chinese battery maker CATL.

Still life of Ozempic and Wegovy with weight scale.

Lawsuit alleges Lilly, Novo locked up telehealth to kill compounded GLP-1s

Novo Nordisk CEO Mike Doustdar estimated that around 1.5 million US patients are using compounded versions of the company’s drugs.

Handshake

Big Pharma enters 2026 with an appetite for deals

At the JPMorgan Healthcare Conference, biotechs and Big Pharma signaled they’re primed for M&A this year, after a big year for deals in 2025.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.